Solana Stock (NASDAQ:HSDT)


ForecastRevenueOwnershipFinancialsChart

Previous Close

$6.70

52W Range

$5.37 - $1.20K

50D Avg

$11.47

200D Avg

$170.05

Market Cap

$282.10M

Avg Vol (3M)

$908.30K

Beta

1.00

Div Yield

-

HSDT Company Profile


Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

21

IPO Date

Jun 27, 2014

Website

HSDT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 21Dec 20Dec 19
Product$493.00K$625.00K$1.45M
Franchise-$9.00K$37.00K
License-$27.00K$5.00K

Fiscal year ends in Dec 24 | Currency in USD

HSDT Financial Summary


Dec 24Dec 23Dec 22
Revenue$520.00K$644.00K$787.00K
Operating Income$-13.90M$-12.43M$-14.76M
Net Income$-11.74M$-8.85M$-12.56M
EBITDA$-13.90M$-12.11M$-14.50M
Basic EPS$-0.43$-14.56$-46.52
Diluted EPS$-0.43$-14.56$-46.52

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 12, 24 | 4:30 PM
Q1 24May 13, 24 | 4:30 PM
Q4 23Mar 28, 24 | 4:30 PM

Peer Comparison


TickerCompany
EXOZeXoZymes, Inc.
CCLDCareCloud, Inc.
QIPTQuipt Home Medical Corp.
SRZNSurrozen, Inc.
NSPRInspireMD, Inc.
PREPrenetics Global Limited
APYXApyx Medical Corporation
LUCDLucid Diagnostics Inc.
FONRFONAR Corporation